Research Article
Magnesium Bioresorbable Scaffold (BRS) Magmaris vs Biodegradable Polymer DES Ultimaster in NSTE-ACS Population—12-Month Clinical Outcome
Table 2
Procedural characteristic.
| Procedural characteristic | Magmaris patients N-193 | Ultimaster patients N-169 | value |
| Treated vessel: LAD | 80 (41.4%) | 65 (38.4%) | 0.592 | LCX | 49 (25.3%) | 47 (27.8%) | 0.634 | RCA | 61 (31.6%) | 56 (33.1%) | 0.626 | IM | 3 (1.6%) | 1 (0.6%) | 0.822 | Predilationballoon: mean diameter (mm) | 3.2 ± 0.3 | 3.1 ± 0.3 | 0.092 | Mean pressure (atm.) | 17.7 ± 0.8 | 15.9 ± 1.9 | <0.001 | Average scaffold number | 1.1 ± 0.2 | 1.2 ± 0.4 | 0.482 | Average scaffold diameter (mm) | 3.28 ± 0.27 | 3.24 ± 0.31 | 0.035 | Average scaffold length (mm) | 20.8 ± 3.3 | 23.9 ± 4.1 | 0.041 | Postdilationballoon: mean diameter (mm) | 3.5 ± 0.3 | 3.3 ± 0.3 | <0.001 | Mean pressure (atm.) | 17.7 ± 0.8 | 16.7 ± 1.0 | <0.001 | 0.0 mm greater than the scaffold | 31 (16.6%) | 120 (71%) | <0.001 | 0.25 mm greater than the scaffold | 130 (65.2%) | 35 (20.7%) | <0.001 | 0.5 mm greater than the scaffold | 32 (18.2%) | 14 (8.3%) | <0.001 | Contrast agent volume (ml) | 151.5 ± 65.4 | 148.5 ± 68.5 | 0.419 | Dose of radiation (mGy) | 1056.7 ± 697.8 | 1244.2 ± 761.1 | 0.008 | OCT/IVUS guided PCI | 41 (21.2%) | 28 (16.7%) | 0.521 | Number of edge dissections | 7 (3.6%) | 7 (5%) | 0.894 | Perforation of the vessel | 0 (0%) | 0 (0%) | 1 | Side branch occlusion | 2 (1%) | 1 (0.6%) | 1 | Antiplatelet therapy acetylsalicylic acid | 191 (98.9%) | 167 (98.8%) | 1 | Clopidogrel | 76 (38.9%) | 148 (87.5%) | <0.001 | Ticagrelor | 117 (60.6%) | 20 (11.9%) | <0.001 |
|
|
Abbreviations: LAD–left anterior descending artery; Cx–circumflex artery; IM-intermedium artery; RCA-right coronary artery; OCT-optical coherent tomography; IVUS-intravascular ultrasound.
|